These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25255328)

  • 1. Pyridoxine-derived bicyclic amido-, ureido-, and carbamato-pyridinols: synthesis and antiangiogenic activities.
    Lee H; Kim DG; Banskota S; Lee YK; Nam TG; Kim JA; Jeong BS
    Org Biomol Chem; 2014 Nov; 12(43):8702-10. PubMed ID: 25255328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antiangiogenic activity of 6-amido-2,4,5-trimethylpyridin-3-ols.
    Lee H; Banskota S; Kim DG; Been JH; Jin YJ; Gautam J; Jang H; Nam TG; Kim JA; Jeong BS
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3131-6. PubMed ID: 24894557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Amino-2,4,5-trimethylpyridin-3-ols: a new general synthetic route and antiangiogenic activity.
    Kim DG; Kang Y; Lee H; Lee EK; Nam TG; Kim JA; Jeong BS
    Eur J Med Chem; 2014 May; 78():126-39. PubMed ID: 24681390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.
    Jung M; Tak J; Chung WY; Park KK
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1227-30. PubMed ID: 16380253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of daumone derivatives and their antiangiogenic activities on chorioallantoic membrane.
    Ricci J; Min D; Oh M; Lim H; Chung WY; Park KK; Jung M
    Med Chem; 2015; 11(8):747-52. PubMed ID: 25974079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of 2,4-disubstituted quinazoline derivatives with potent anti-angiogenesis activities.
    Yu G; Li Z; Tang L; Xiong Q
    Molecules; 2014 Jun; 19(7):8916-32. PubMed ID: 24972275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel VEGFR-2 inhibitors with an N-acylhydrazone scaffold.
    Pauli FP; Martins JR; Paschoalin T; Ionta M; Barbosa MLC; Barreiro EJ
    Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000130. PubMed ID: 32667721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-alpha-induced angiogenesis in chick chorioallantoic membrane (CAM).
    Ayalasomayajula SP; Ashton P; Kompella UB
    J Ocul Pharmacol Ther; 2009 Apr; 25(2):97-103. PubMed ID: 19284324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.
    Nagaraju GP; Zhu S; Ko JE; Ashritha N; Kandimalla R; Snyder JP; Shoji M; El-Rayes BF
    Cancer Lett; 2015 Feb; 357(2):557-65. PubMed ID: 25497868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periplasmic expression optimization of VEGFR2 D3 adopting response surface methodology: antiangiogenic activity study.
    Cao W; Li H; Zhang J; Li D; Acheampong DO; Chen Z; Wang M
    Protein Expr Purif; 2013 Aug; 90(2):55-66. PubMed ID: 23680780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
    Gao W; Jin K; Lan H; Han N; Cao F; Teng L
    Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triterpenes from leaves of Cheiloclinium cognatum and their in vivo antiangiogenic activity.
    Pereira RCG; Soares DCF; Oliveira DCP; de Sousa GF; Vieira-Filho SA; Mercadante-Simões MO; Lula I; Silva-Cunha A; Duarte LP
    Magn Reson Chem; 2018 May; 56(5):360-366. PubMed ID: 29388257
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and preliminary evaluation of 5,7-dimethyl-2-aryl-3H-pyrrolizin-3-ones as angiogenesis inhibitors.
    Kirk NS; Bezos A; Willis AC; Sudta P; Suksamrarn S; Parish CR; Ranson M; Kelso MJ
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1813-6. PubMed ID: 26912111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Choline promotes angiogenesis in chick embryo chorioallantoic membrane].
    Wang H; Zeng XZ; Cui WY; Duan L
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 May; 29(3):229-31. PubMed ID: 23940955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities.
    An ZY; Yan YY; Peng D; Ou TM; Tan JH; Huang SL; An LK; Gu LQ; Huang ZS
    Eur J Med Chem; 2010 Sep; 45(9):3895-903. PubMed ID: 20554355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: selection of the scaffold.
    Jones ED; Vandegraaff N; Le G; Choi N; Issa W; Macfarlane K; Thienthong N; Winfield LJ; Coates JA; Lu L; Li X; Feng X; Yu C; Rhodes DI; Deadman JJ
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5913-7. PubMed ID: 20727748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
    Hosseini H; Rajabibazl M; Ebrahimizadeh W; Dehbidi GR
    Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avian area vasculosa and CAM as rapid in vivo pro-angiogenic and antiangiogenic models.
    Makanya AN; Styp-Rekowska B; Dimova I; Djonov V
    Methods Mol Biol; 2015; 1214():185-96. PubMed ID: 25468605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semisynthesis and pharmacological activities of Tetrac analogs: angiogenesis modulators.
    Bridoux A; Cui H; Dyskin E; Yalcin M; Mousa SA
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3259-63. PubMed ID: 19427201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.